Half-year report · Q2
3747.TEDINET S100VRG8
Period2024-10-01 → 2025-03-31
Filed2025-05-15
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥863m | 2024-10-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥1.8bn | 2023-10-01 → 2024-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥940m | 2023-10-01 → 2024-03-31 | Cons. | Net sales |
| Operating income | ¥16m | 2024-10-01 → 2025-03-31 | Cons. | Operating income |
| Operating income | ¥62m | 2023-10-01 → 2024-03-31 | Cons. | Operating income |
| Ordinary income | −¥85m | 2024-10-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | −¥160m | 2023-10-01 → 2024-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥27m | 2023-10-01 → 2024-03-31 | Cons. | Ordinary income |
| Profit before tax | −¥38m | 2024-10-01 → 2025-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥32m | 2023-10-01 → 2024-03-31 | Cons. | Income before income taxes |
| Net income (owners) | −¥40m | 2024-10-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥98m | 2023-10-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥20m | 2023-10-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥49m | 2024-10-01 → 2025-03-31 | Cons. | Profit loss |
| Net income | ¥17m | 2023-10-01 → 2024-03-31 | Cons. | Profit loss |
| Total assets | ¥1.6bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥1.6bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥1.7bn | at 2024-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥411m | at 2025-03-31 | Cons. | Liabilities |
| Total liabilities | ¥413m | at 2024-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥1.2bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥1.2bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥1.3bn | at 2024-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥819m | at 2025-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.0bn | at 2024-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥819m | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.0bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥994m | at 2023-09-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥20m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥81m | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥106m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥202m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥124m | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥16m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥24m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥73m | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥14m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-5.53 | 2024-10-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-13.63 | 2023-10-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥2.82 | 2023-10-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 74.1% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.2% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.4% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 34
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-10-01 → 2025-03-31 | −¥12,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2024-10-01 → 2025-03-31 | −¥12,000 |
| Reconciling Itemsreconciling | segment profit | 2024-10-01 → 2025-03-31 | −¥162m |
| jpcrp040300-q2r_E05424-000Business Solutionreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥125m |
| jpcrp040300-q2r_E05424-000Business Solutionreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥125m |
| jpcrp040300-q2r_E05424-000Business Solutionreportable segment | segment profit | 2024-10-01 → 2025-03-31 | −¥21m |
| jpcrp040300-q2r_E05424-000Financial Solutionreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥682m |
| jpcrp040300-q2r_E05424-000Financial Solutionreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥682m |
| jpcrp040300-q2r_E05424-000Financial Solutionreportable segment | segment profit | 2024-10-01 → 2025-03-31 | ¥224m |
| jpcrp040300-q2r_E05424-000Health Carereportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥55m |
| jpcrp040300-q2r_E05424-000Health Carereportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥55m |
| jpcrp040300-q2r_E05424-000Health Carereportable segment | revenue intersegment | 2024-10-01 → 2025-03-31 | ¥12,000 |
| jpcrp040300-q2r_E05424-000Health Carereportable segment | segment profit | 2024-10-01 → 2025-03-31 | −¥24m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-10-01 → 2025-03-31 | ¥863m |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-10-01 → 2025-03-31 | ¥863m |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-10-01 → 2025-03-31 | ¥12,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-10-01 → 2025-03-31 | ¥178m |
| Reconciling Itemsreconciling | revenue | 2023-10-01 → 2024-03-31 | −¥30,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2023-10-01 → 2024-03-31 | −¥30,000 |
| Reconciling Itemsreconciling | segment profit | 2023-10-01 → 2024-03-31 | −¥151m |
| jpcrp040300-q2r_E05424-000Business Solutionreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥131m |
| jpcrp040300-q2r_E05424-000Business Solutionreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥131m |
| jpcrp040300-q2r_E05424-000Business Solutionreportable segment | segment profit | 2023-10-01 → 2024-03-31 | −¥5m |
| jpcrp040300-q2r_E05424-000Financial Solutionreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥751m |
| jpcrp040300-q2r_E05424-000Financial Solutionreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥751m |
| jpcrp040300-q2r_E05424-000Financial Solutionreportable segment | segment profit | 2023-10-01 → 2024-03-31 | ¥240m |
| jpcrp040300-q2r_E05424-000Health Carereportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥59m |
| jpcrp040300-q2r_E05424-000Health Carereportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥59m |
| jpcrp040300-q2r_E05424-000Health Carereportable segment | revenue intersegment | 2023-10-01 → 2024-03-31 | ¥30,000 |
| jpcrp040300-q2r_E05424-000Health Carereportable segment | segment profit | 2023-10-01 → 2024-03-31 | −¥22m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-10-01 → 2024-03-31 | ¥940m |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-10-01 → 2024-03-31 | ¥940m |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-10-01 → 2024-03-31 | ¥30,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-10-01 → 2024-03-31 | ¥213m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 481
| Item | Context | Value | Unit |
|---|---|---|---|
| Repayment of long term loans payable fin cf | Prior1YTDDuration | -10020000 | JPY |
| Repayment of long term loans payable fin cf | CurrentYTDDuration | -20016000 | JPY |
| Repayments of lease obligations fin cf | Prior1YTDDuration | -3569000 | JPY |
| Repayments of lease obligations fin cf | CurrentYTDDuration | -4059000 | JPY |
| Purchase of treasury stock fin cf | Prior1YTDDuration | － | JPY |
| Purchase of treasury stock fin cf | CurrentYTDDuration | -14000 | JPY |
| Other net fin cf | Prior1YTDDuration | -33000 | JPY |
| Other net fin cf | CurrentYTDDuration | － | JPY |
| Net cash provided by used in financing activities | Prior1YTDDuration | -13622000 | JPY |
| Net cash provided by used in financing activities | CurrentYTDDuration | -24090000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration | 75952000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | -206346000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 994380000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 1024922000 | JPY |
| Cash and cash equivalents | Prior1QuarterInstant | 1070332000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 818576000 | JPY |
| Directors compensations sga | Prior1YTDDuration | 41664000 | JPY |
| Directors compensations sga | CurrentYTDDuration | 42654000 | JPY |
| Payroll and allowances sga | Prior1YTDDuration | 68370000 | JPY |
| Payroll and allowances sga | CurrentYTDDuration | 70006000 | JPY |
| Depreciation sga | Prior1YTDDuration | 991000 | JPY |
| Depreciation sga | CurrentYTDDuration | 847000 | JPY |
| Research and development expenses sga | Prior1YTDDuration | 29385000 | JPY |
| Research and development expenses sga | CurrentYTDDuration | 13872000 | JPY |
| Retirement benefit expenses sga | Prior1YTDDuration | 4228000 | JPY |
| Retirement benefit expenses sga | CurrentYTDDuration | 8614000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E05424-000FinancialSolutionReportableSegmentsMember | 750734000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E05424-000BusinessSolutionReportableSegmentsMember | 131032000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E05424-000HealthCareReportableSegmentsMember | 58576000 | JPY |
| Revenues from external customers | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 940343000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 940343000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E05424-000FinancialSolutionReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E05424-000BusinessSolutionReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E05424-000HealthCareReportableSegmentsMember | 30000 | JPY |
| Transactions with other segments | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 30000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | -30000 | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E05424-000FinancialSolutionReportableSegmentsMember | 750734000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E05424-000BusinessSolutionReportableSegmentsMember | 131032000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E05424-000HealthCareReportableSegmentsMember | 58607000 | JPY |
| Net sales | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 940374000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -30000 | JPY |
| Net sales | Prior1YTDDuration | 940343000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E05424-000FinancialSolutionReportableSegmentsMember | 240341000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E05424-000BusinessSolutionReportableSegmentsMember | -4858000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E05424-000HealthCareReportableSegmentsMember | -22424000 | JPY |
| Operating income | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 213059000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | -151427000 | JPY |
| Operating income | Prior1YTDDuration | 61632000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |